Alpine Immune Sciences Inc (ALPN)
64.59
+0.01
(+0.02%)
USD |
NASDAQ |
May 01, 10:20
Alpine Immune Sciences Market Cap: 4.235B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 4.234B |
| April 29, 2024 | 4.242B |
| April 26, 2024 | 4.233B |
| April 25, 2024 | 4.237B |
| April 24, 2024 | 4.233B |
| April 23, 2024 | 4.232B |
| April 22, 2024 | 4.234B |
| April 19, 2024 | 4.232B |
| April 18, 2024 | 4.224B |
| April 17, 2024 | 4.226B |
| April 16, 2024 | 4.229B |
| April 15, 2024 | 4.223B |
| April 12, 2024 | 4.220B |
| April 11, 2024 | 4.222B |
| April 10, 2024 | 3.084B |
| April 09, 2024 | 2.553B |
| April 08, 2024 | 2.526B |
| April 05, 2024 | 2.288B |
| April 04, 2024 | 2.316B |
| April 03, 2024 | 2.498B |
| April 02, 2024 | 2.570B |
| April 01, 2024 | 2.636B |
| March 28, 2024 | 2.598B |
| March 27, 2024 | 2.533B |
| March 26, 2024 | 2.455B |
| Date | Value |
|---|---|
| March 25, 2024 | 2.461B |
| March 22, 2024 | 2.579B |
| March 21, 2024 | 2.727B |
| March 20, 2024 | 2.637B |
| March 19, 2024 | 2.619B |
| March 18, 2024 | 2.325B |
| March 15, 2024 | 2.385B |
| March 14, 2024 | 2.352B |
| March 13, 2024 | 2.400B |
| March 12, 2024 | 2.389B |
| March 11, 2024 | 2.319B |
| March 08, 2024 | 2.355B |
| March 07, 2024 | 2.425B |
| March 06, 2024 | 2.526B |
| March 05, 2024 | 2.456B |
| March 04, 2024 | 2.403B |
| March 01, 2024 | 2.359B |
| February 29, 2024 | 2.308B |
| February 28, 2024 | 2.289B |
| February 27, 2024 | 2.357B |
| February 26, 2024 | 2.277B |
| February 23, 2024 | 2.223B |
| February 22, 2024 | 2.170B |
| February 21, 2024 | 1.992B |
| February 20, 2024 | 2.000B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
39.99M
Minimum
Mar 17 2020
4.242B
Maximum
Apr 29 2024
416.93M
Average
265.64M
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 101.77B |
| Eliem Therapeutics Inc | 195.42M |
| Regeneron Pharmaceuticals Inc | 97.73B |
| Vera Therapeutics Inc | 2.257B |
| Eyenovia Inc | 37.68M |
Market Cap Related Metrics
| PS Ratio | 54.85 |
| Price to Book Value | 12.91 |
| Price | 64.59 |
| Earnings Yield | -0.99% |